1
Josef Apolet, Romano Ballotta, Giovanni Cavallo: Irrigation device for use in ear canals for therapeutic or hygienic purposes. D D S R L, Oliff & Berridge, November 15, 1994: US05364343 (21 worldwide citation)

An irrigation device for use in an ear canal is a main body of substantially conical shape having a central axis. There is at least one input duct connecting to a lavage liquid delivery apparatus for injecting the lavage liquid into the ear canal. There is at least one output duct allowing the conti ...


2
Ezio Tubaro, Giovanni Cavallo: Ganglioside derivatives. Burroughs Wellcome Co, Donald Brown, March 1, 1988: US04728641 (13 worldwide citation)

A novel mono-sialo ganglioside derivative substantially identical chemically and physically with a product prepared by


3
Ezio Tubaro, Giovanni Cavallo: Ganglioside derivatives. Burroughs Wellcome Co, Donald Brown, May 16, 1989: US04831021 (7 worldwide citation)

A novel mono-sialo ganglioside derivative substantially identical chemically and physically with a product prepared by


4
Ezio Tubaro, Giovanni Cavallo: Di-N-deacetyl-lysogangliosides. Wellcome Foundation, Nixon & Vanderhye, January 25, 1994: US05281702 (4 worldwide citation)

The invention relates to N-deacetyl-lysogangliosides and physiologically acceptable salts thereof, especially those of formula (I): ##STR1## wherein R represents --CH.dbd.CH(CH.sub.2)nCH.sub.3 or --CH.sub.2 CH.sub.2 (CH.sub.2)nCH.sub.3 ;


5

6

7

8
Giovanni Cavallo, Mario Pinza: Pharmaceutical composition for injection based on paracetamol. Aziende Chimiche Riunite Angelini Francesco A C R A F S p A, Oblon Spivak McClelland Maier & Neustadt P C, July 23, 2002: US06423749 (1 worldwide citation)

The invention relates to pharmaceutical compositions comprising paracetamol, ethanol, and polyethylene glycol, either in the absence or the presence of water.


9
Fulvio Foschini, Pierre Roy, Edoardo Stagni, Giovanni Cavallo, Giulio Luciani: Device and method for corneal delivery of riboflavin by iontophoresis for the treatment of keratoconus. SOOFT ITALIA, Young & Thompson, July 11, 2017: US09700456

Ocular iontophoresis device and method for delivering any ionized drug solution to the cornea includes: a reservoir containing a solution suitable to be positioned on the eye; an active electrode disposed in or on the reservoir; and a passive electrode suitable to be placed on the skin of the subjec ...


10
Marcello STAGNI, Edoardo STAGNI, Massimo FILIPPELLO, Giovanni CAVALLO, Eugenio SODO: Use of enhancers, possibly associated to riboflavin, as well as corresponding ophthalmic compositions for corneal cross-linking in the treatment of the keratoconus or of other corneal ectasic disorders. Sooft Italia, June 23, 2011: US20110152219-A1

The use of enhancers with possibly riboflavin, as well as the corresponding compositions for the treatment of keratoconus or other ectasic corneal disorders by the method of corneal cross-linking.



Click the thumbnails below to visualize the patent trend.